Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885726 · ClinicalTrials.gov registry record · NA
HVNI Ambulation Feasibility Study
A NA study, sponsored by Vapotherm.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03885726 is a NA study that has completed, run by Vapotherm. The registered enrollment target is 32 participants.
The verdict
NCT03885726, a NA study, has completed, sponsored by Vapotherm.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The pilot/feasibility study evaluates the ability of High Velocity Nasal Insufflation (HVNI) therapy to facilitate ambulation and mobilization in patients experiencing shortness of breath, as compared to simple oxygen therapy.
Interventions
- DEVICE Precision Flow Plus
- DEVICE Treatment as Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-11-21 |
| Est. Completion | 2019-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03885726
The ClinicalTrials.gov registry entry for NCT03885726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vapotherm, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Precision Flow Plus is the first listed.
NCT03885726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03885726 about?
NCT03885726 is a clinical study titled "HVNI Ambulation Feasibility Study". The pilot/feasibility study evaluates the ability of High Velocity Nasal Insufflation (HVNI) therapy to facilitate ambulation and mobilization in patients experiencing shortness of breath, as compared to simple oxygen therapy.
What is the current status of trial NCT03885726?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-11-21. Estimated completion is 2019-03-11.
What interventions are being tested in trial NCT03885726?
The interventions under investigation include: Precision Flow Plus (DEVICE), Treatment as Usual (DEVICE).
Who is sponsoring clinical trial NCT03885726?
This trial is sponsored by Vapotherm, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.